Physician profile
Geoffrey Rose
NPI 1013920123
$3,813.82
in general payments reported to CMS, 2019-2025
10 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,694 · 2021: $97.14 · 2022: $447 · 2023: $249 · 2024: $131 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,415.16 | 2019 | |
| Heartflow, INC. | $710.20 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $205.51 | 2022-2023 | Xarelto |
| Medtronic, INC. | $169.83 | 2022 | |
| Boston Scientific Corporation | $106.93 | 2022-2025 | General - Ep |
| Ge Healthcare | $94.86 | 2025 | |
| Janssen Pharmaceuticals, INC | $33.75 | 2023 | Xarelto |
| Siemens Medical Solutions USA, INC. | $29.65 | 2023 | Acuson Sequoia Diagnostic Ultrasound System |
| Abiomed | $25.47 | 2025 | |
| Novartis Pharmaceuticals Corporation | $22.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.